The TGFβ growth suppressive pathway is commonly disrupted in pancreatic cancer, most often through mutation/deletion of SMAD4, but also through inactivation/loss of TGFβRI and TGFβRII[4]. This evidence concerns the gene TGFB1 and pancreatic neoplasm.